Eli Lilly (LLY) returns
Eli Lilly returns over 10 years
$1,000 invested in Eli Lilly ten years ago was worth $22,241 at the close on October 30, 2026, with dividends reinvested: an average return of 36.4% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +22.5% | — | $1,225 | -0.9% |
| 3 months | +22.9% | — | $1,229 | +2.1% |
| Year to date | +32.5% | — | $1,325 | +11.7% |
| 1 year | +68.9% | — | $1,689 | +12.4% |
| 3 years | +155.8% | +36.8% | $2,558 | +88.5% |
| 5 years | +482.2% | +42.2% | $5,822 | +76.0% |
| 10 years | +2,124% | +36.4% | $22,241 | +316.6% |
Eli Lilly return by calendar year
| Year | LLY | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +32.5% | +11.7% | +20.9% |
| 2025 | +40.2% | +17.7% | +22.5% |
| 2024 | +33.3% | +24.9% | +8.4% |
| 2023 | +60.9% | +26.2% | +34.7% |
| 2022 | +34.2% | -18.2% | +52.4% |
| 2021 | +66.1% | +28.7% | +37.3% |
| 2020 | +31.1% | +18.4% | +12.7% |
| 2019 | +16.2% | +31.2% | -15.1% |
| 2018 | +40.4% | -4.6% | +45.0% |
| 2017 | +17.8% | +21.7% | -3.9% |
| 2016 | -10.4% | +12.0% | -22.4% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: LLY financials · LLY valuation
No forecast, no recommendation. This page describes Eli Lilly from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.